Vanhee Celine, Degrève Cloë, Boschmans Niels, Naïmi Yasmina, Canfyn Michael, Deconinck Eric, Willocx Marie
Service Medicines and Health Products, Scientific Direction of Chemical and Physical Health Risks, Sciensano, J. Wytsmanstraat 14, B-1050 Brussels, Belgium.
Molecules. 2025 Jun 19;30(12):2647. doi: 10.3390/molecules30122647.
The global sleep aids market has grown significantly due to rising stress and increased awareness of sleep's importance. Melatonin, available in the EU as a prescription or over-the-counter medicine, depending on the country, is also permitted in dietary supplements with country-specific limits. Recent reports indicate concerning levels of excessive melatonin in EU dietary supplements, necessitating accurate quantification methods. We developed and validated, by applying accuracy profiles, ISO17025-compliant, rapid ultra-high performance liquid chromatography (UHPLC) methodologies coupled with either diode array detection (DAD) or high-resolution accurate mass spectrometry (HRAM MS). The cost-effective UHPLC-DAD method is suitable for medicines and most dietary supplements, except those more complex herbal matrices containing passionflower, hop, hemp, lime tree or lavender or their extracts, where UHPLC-HRAM MS is recommended due to selectivity issues of the DAD methodology. To demonstrate the applicability, we analyzed 50 dietary supplements claiming to contain melatonin-25 from legal supply chains and 25 from suspicious sources claiming therapeutic melatonin content. Our findings confirmed previous reports of high melatonin content in online products, especially when purchased through rogue internet pharmacies. Moreover, 12% of legal supply chain samples violated current legislation through unauthorized health claims or contained at least triple the melatonin amount permitted in Belgium. This research provides reliable analytical methods for regulatory bodies and confirms the circulation of non-compliant melatonin-containing dietary supplements in the EU market, even in the legal supply chain.
由于压力增加以及人们对睡眠重要性的认识提高,全球睡眠辅助产品市场显著增长。褪黑素在欧盟可作为处方药或非处方药使用,具体取决于国家,在膳食补充剂中也被允许使用,但有特定国家的限量规定。最近的报告表明,欧盟膳食补充剂中存在令人担忧的过量褪黑素水平,因此需要准确的定量方法。我们通过应用准确度分布图,开发并验证了符合ISO17025标准的、快速的超高效液相色谱(UHPLC)方法,该方法结合了二极管阵列检测(DAD)或高分辨率精确质量质谱(HRAM MS)。具有成本效益的UHPLC-DAD方法适用于药品和大多数膳食补充剂,但不包括那些含有西番莲、啤酒花、大麻、菩提树或薰衣草或其提取物的更复杂草药基质的产品,由于DAD方法的选择性问题,对于这些产品推荐使用UHPLC-HRAM MS。为了证明其适用性,我们分析了50种声称含有褪黑素的膳食补充剂,这些产品来自合法供应链,还有25种来自可疑来源,声称含有治疗性褪黑素成分。我们的研究结果证实了先前关于在线产品中褪黑素含量高的报道,尤其是通过非法网络药店购买的产品。此外,12%的合法供应链样本通过未经授权的健康声明违反了现行法规,或者所含褪黑素量至少是比利时允许量的三倍。这项研究为监管机构提供了可靠的分析方法,并证实了不符合规定的含褪黑素膳食补充剂在欧盟市场流通,即使是在合法供应链中。